CAN NOVEL AGENTS OVERCOME THE NEGATIVE PROGNOSTIC IMPACT OF RENAL IMPAIRMENT IN MULTIPLE MYELOMA? - A POPULATION BASED STUDY INCLUDING 1538 PATIENTS

被引:0
|
作者
Uttervall, K. [1 ]
Lund, J. [1 ]
Liwing, J. [1 ]
Holmberg, E. [2 ]
Alici, E. [1 ]
Aschan, J. [3 ]
Nahi, H. [1 ]
机构
[1] Karolinska Inst, Dept Med, Stockholm, Sweden
[2] Univ Gothenburg, Dept Oncol, Inst Clin Sci, Sahlgrenska Acad, Gothenburg, Sweden
[3] Janssen Cilag AB, Sollentuna, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P781
引用
收藏
页码:326 / 327
页数:2
相关论文
共 50 条
  • [31] Cognitive Impairment Is a Negative Prognostic Indicator in ALS: A Population Based Study
    Elamin, Marwa
    Phukan, Julie
    Byrne, Susan
    Jordan, Norah
    Pender, Nail
    Hardiman, Orla
    NEUROLOGY, 2010, 74 (09) : A201 - A201
  • [32] Risk of Infections in Multiple Myeloma in the Era of Novel Agents, a Population-Based Study Based on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry
    Blimark, Cecilie Hveding
    Carlson, Kristina
    Day, Christopher
    Einarsdottir, Sigrun
    Juliusson, Gunnar
    Karma, Moshtak
    Knut-Bojanowska, Dorota
    Larfors, Gunnar
    Turesson, Ingemar
    Scivetti, Mariana Villegas
    Sverrisdottir, Ingigerdur
    BLOOD, 2023, 142
  • [33] Superior myeloma response with bortezomib-based regimen in multiple myeloma patients with renal impairment
    Bao, Li
    Lu, Jin
    Wang, Shihua
    Huang, Xiaojun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 6200 - 6209
  • [34] Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients
    Chen, Xuduan
    Luo, Xiaofeng
    Zu, Yanping
    Issa, Hajji Ally
    Li, Linlin
    Ye, Hong
    Yang, Ting
    Hu, Jianda
    Wei, Lixin
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (09)
  • [35] The Reversal of Renal Impairment and its Impact on Survival in Newly Diagnosed Multiple Myeloma Patients
    Gonsalves, Wilson I.
    Leung, Nelson
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Buadi, Francis K.
    Lacy, Martha Q.
    Dingli, David
    Kapoor, Prashant
    Lust, John A.
    Go, Ronald S.
    Hayman, Suzanne R.
    Lin, Yi
    Zeldenrust, Steven
    Kyle, Robert A.
    Gertz, Morie A.
    Kumar, Shaji K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S239 - S239
  • [36] Impact of Novel Agents on Young Patients with t(11;14) Multiple Myeloma
    Paludo, Jonas
    Vallumsetla, Nishanth
    Kumar, Shaji
    Ketterling, Rhett
    Gertz, Morie A.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Buadi, Francis K.
    Dingli, David
    Painuly, Utkarsh
    Leung, Nelson
    Kyle, Robert
    Rajkumar, S. Vincent
    Kapoor, Prashant
    BLOOD, 2014, 124 (21)
  • [37] Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
    Blimark, Cecilie
    Holmberg, Erik
    Mellqvist, Ulf-Henrik
    Landgren, Ola
    Bjoekholm, Magnus
    Hultcrantz, Malin
    Kjellander, Christian
    Turesson, Ingemar
    Kristinsson, Sigurdur Y.
    HAEMATOLOGICA, 2015, 100 (01) : 107 - 113
  • [38] Impact of dialysis dependence on survival for multiple myeloma with renal impairment: a multicenter study in China
    Jian, Yuan
    Zhou, Huixing
    Xie, Weiwei
    Ren, Yuan
    Zhang, Zhiyao
    Yang, Guangzhong
    Geng, Chuanying
    Jia, Jing
    Chen, Wenming
    Huang, Wenrong
    Cen, Xinan
    Gao, Wen
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (04): : 1571 - 1581
  • [39] MULTIPLE MYELOMA PATIENTS THAT DEVELOP SECOND PRIMARY MALIGNANCY HAVE A WORSE PROGNOSIS THAN MULTIPLE MYELOMA PATIENTS TREATED BEFORE THE INTRODUCTION OF NOVEL AGENTS: A POPULATION BASED-STUDY
    Jonsdottir, G.
    Lund, S. H.
    Landgren, O.
    Bjorkholm, M.
    Turesson, I.
    Wahlin, A.
    Blimark, C.
    Hultcrantz, M.
    Porwit, A.
    Kristinsson, S. Y.
    HAEMATOLOGICA, 2014, 99 : 116 - 117
  • [40] IMMUNOPHENOTYPIC REMISSIONS CAN BE ACHIEVED IN ELDERLY MULTIPLE MYELOMA PATIENTS TREATED WITH NOVEL AGENTS
    Paiva, Bruno
    Vidriales, Maria-Belen
    Montalban, Maria A.
    Martinez, Joaquin
    Fernandez-Redondo, Elena
    Mateos, Maria-Victoria
    Gutierrez, Norma C.
    Lopez-Corral, Lucia
    Perez, Jose J.
    Martin, Alejandro
    Terol, Maria J.
    Gonzalez, Yolanda
    Echebeste, Maria A.
    Hernandez, Jose
    De Arriba, Felipe
    De Paz, Raquel
    Blade, Joan
    Lahuerta, Juan J.
    Orfao, Alberto
    San Miguel, Jesus F.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 454 - 454